Human cytokine responses to coronary artery bypass grafting with and without cardiopulmonary bypass

Citation
M. Struber et al., Human cytokine responses to coronary artery bypass grafting with and without cardiopulmonary bypass, ANN THORAC, 68(4), 1999, pp. 1330-1335
Citations number
25
Categorie Soggetti
Cardiovascular & Respiratory Systems","Medical Research Diagnosis & Treatment
Journal title
ANNALS OF THORACIC SURGERY
ISSN journal
00034975 → ACNP
Volume
68
Issue
4
Year of publication
1999
Pages
1330 - 1335
Database
ISI
SICI code
0003-4975(199910)68:4<1330:HCRTCA>2.0.ZU;2-N
Abstract
Background. Coronary artery bypass grafting (CABG) is associated with a sys temic inflammatory response. This has been attributed to cytokine release c aused by extracorporeal circulation and myocardial ischemia. This study com pares the inflammatory response after CABG with cardiopulmonary bypass and after minimally invasive direct coronary artery bypass grafting (MIDCABG) w ithout cardiopulmonary bypass. Methods. Cytokine release and complement activation (interleukin-6 and inte rleukin-8, soluble tumor necrosis factor receptors 1 and 2, complement fact or C3a, and CI esterase inhibitor) were determined in 24 patients before an d after CABG or MIDCABG. The maximum body temperature, chest drainage, and fluid balance were recorded for 24 hours after operation. Results. Release of interleukin-6, interleukin-8, and tumor necrosis factor receptors 1 and 2 was significantly higher (p less than or equal to 0.005) in the CABG group than the MIDCABG group just after operation, After 24 ho urs, a significant increase in interleukin-6 was also found in the MIDCABG group (p = 0.001) compared with preoperative value. Body temperature and fl uid balance were significantly higher after CABG (p less than or equal to 0 .001). Conclusions. Minimally invasive direct coronary artery bypass grafting repr esents a less traumatizing technique of surgical revascularization. The red uction in the inflammatory response may be advantageous for patients with a high degree of comorbidity. (C) 1999 by The Society of Thoracic Surgeons.